Panacea Biotec Limited (NSE:PANACEABIO)

India · Delayed Price · Currency is INR

354.30

-7.95 (-2.19%)

Feb 18, 2026, 3:15 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Vaccines	3.10B	3.60B	2.57B	2.35B	2.28B
Vaccines Growth	-13.83%	39.93%	9.46%	3.04%	62.26%
Formulations	2.49B	2.00B	2.03B	4.26B	3.97B
Formulations Growth	24.89%	-1.67%	-52.41%	7.43%	-1.65%
Total	5.59B	5.59B	4.60B	6.61B	6.25B
Total Growth	-0.01%	21.57%	-30.44%	5.83%	14.84%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	1.58B	777.68M	1.11B	3.73B	3.11B
India Growth	103.59%	-29.90%	-70.23%	19.85%	-16.28%
Overseas	4.01B	4.81B	3.49B	2.89B	3.14B
Overseas Growth	-16.75%	37.94%	20.92%	-8.05%	81.78%
Total	5.59B	5.59B	4.60B	6.61B	6.25B
Total Growth	-0.01%	21.57%	-30.44%	5.83%	14.84%

Source: S&P Global Market Intelligence.